Akari Therapeutics, Plc (AKTX)

Import this data to Google Sheets with:

=jivedata("AKTX","financials")

Full statements spill as a table. For one cell: =jivedata("AKTX","Revenue") or =jivedata("AKTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Akari Therapeutics, Plc

AKTX • CIK 0001541157

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$5,450	$6,983	$2,815	$4,871
Selling, General and Administrative Expense	$11,356	$9,664	$9,280	$8,810
Operating Income (Loss)	$-16,806	$-21,643	$-17,275	$-30,991
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$5,180	$5,180
Business Combination, Acquisition Related Costs	—	$3,273	$3,273	$3,273
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-10.008	$-19,791	$-18,301	$-32,822
Restructuring Costs	—	$1,723	$1,723	$1,723
Income Tax Expense (Benefit)	$0	$0	$-1,003	$-1,862
Operating Expenses	—	$21,643	$17,275	$29,508
Net Income (Loss) Attributable to Parent	$-10,008	$-19,791	$-17,298	$-30,960
Weighted Average Number of Shares Outstanding, Basic	9,788,980,193	23,888,010,485	67,328,128,638	139,599,280,308
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-10,277	$-19,489	$-17,342	$-30,549
Investment Income, Interest	$82	$8	$1	$1
InterestExpenseNonoperating	—	$244	$949	$985
Gain (Loss) on Extinguishment of Debt	—	—	$-3,164	$-3,164
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$6,599	$2,085	$775	$640
Derivative, Gain (Loss) on Derivative, Net	—	—	$-230	$-230
Foreign Currency Transaction Gain (Loss), Realized	$136	$6	$-443	$-230
Other Nonoperating Expense	—	—	$3	$3
Nonoperating Income (Expense)	—	$1,852	$-1,026	$-1,831
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$-269	$302	$-44	$411
Share-based Payment Arrangement, Expense	$1,150	$2,245	$2,890	$2,172

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash	—	$2,599	$5,203	$7,694
Restricted Cash	—	$60	$60	$60
Goodwill	—	$8,430	$8,430	$8,430
Prepaid Expense, Current	$299	$92	$185	$532
Other Intangible Assets, Net	—	$39,180	$34,000	$30,300
Other Assets, Current	$197	$201	$14	$38
Assets	$4,355	$50,562	$47,892	$38,624
Assets, Current	$4,341	$2,952	$5,462	$8,324
Derivative Liability, Noncurrent	—	—	$230	$230
Other Liabilities, Noncurrent	—	$383	$31	$31
Deferred Income Tax Liabilities, Net	—	$8,040	$6,952	$6,094
Liabilities	$4,584	$28,333	$19,564	$20,029
Accounts Payable, Current	$1,671	$12,407	$8,770	$9,401
Accrued Liabilities, Current	$1,566	$3,137	$2,342	$3,513
Convertible Debt	—	$700	$673	$693
Notes Payable, Current	—	$659	$81	$49
Other Liabilities, Current	$94	$94	$424	$212
Liabilities, Current	—	$19,910	$12,351	$13,935
Common Stock, Value, Issued	$1,324	$5,319	$5,319	$1
Additional Paid in Capital	—	—	$234,318	$243,759
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-1,040	$-738	$-782	$-695
Retained Earnings (Accumulated Deficit)	$-227,461	$-247,252	$-264,550	$-283,812
Stockholders' Equity Attributable to Parent	$-229	$22,229	$28,328	$18,595
Common Stock, Shares Authorized	45,122,321,523	245,035,791,523	761,963,201,733	4,365,687,180,943
Common Stock, Shares, Issued	13,234,315,298	53,186,919,523	90,536,879,533	140,032,769,533

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-10,008	$-19,791	$-17,298	$-30,960
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$7	$-4	$1	$1
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-9,405	$-1,186	$2,604	$4,983
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$3,845	$2,659	$5,263	$5,449
Depreciation, Depletion and Amortization	$4	$14	$14	$14
Cash Acquired from Acquisition	—	$382	$382	$382
Share-based Payment Arrangement, Noncash Expense	$1,150	$2,245	$2,890	$2,172
Issuance of Stock and Warrants for Services or Claims	$142	$271	$27	$27
Gain (Loss) on Extinguishment of Debt	—	—	$-3,164	$-3,164
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$6,599	$2,085	$775	$640
Asset Impairment Charges	—	—	$5,180	$5,180
Derivative, Gain (Loss) on Derivative, Net	—	—	$-230	$-230
Deferred Income Tax Expense (Benefit)	—	—	$-1,088	$-1,088
Foreign Currency Transaction Gain (Loss), before Tax	$255	—	$99	$-343
Net Cash Provided by (Used in) Operating Activities	$-16,432	$-12,552	$-10,568	$-10,759
Proceeds from Issuance of Common Stock	$7,016	$11,815	$10,725	$10,725
Proceeds from Issuance of Warrants	—	—	$1,036	$1,036
Proceeds from Notes Payable	—	—	$2,099	$2,099
Proceeds from Convertible Debt	—	$1,000	$1,000	$1,000
Repayments of Debt	—	—	$553	$553
Proceeds from Other Equity	—	—	$26	$26
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$4	$2	$33	$33
Proceeds from Warrant Exercises	$94	—	$330	$330
Repayments of Short-term Debt	—	$1,105	$499	$483
Net Cash Provided by (Used in) Financing Activities	$7,020	$10,988	$13,171	$15,745
Cash	—	$2,599	$5,203	$5,389
Restricted Cash	—	$60	$60	$60
Restricted Cash and Cash Equivalents	—	$2,659	$5,263	$5,449
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$143	$101	$103
Increase (Decrease) in Prepaid Expenses, Other	—	—	$-594	$-429
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-936	$5,223	$-998	$668

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("AKTX","financials")

Full statements spill as a table. For one cell: =jivedata("AKTX","Revenue") or =jivedata("AKTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.